Moderna, Inc.MRNANASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank22
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Percentile
P22
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025$-2.55B+24.8%
2024$-3.39B-3.4%
2023$-3.28B-133.6%
2022$9.77B-27.8%
2021$13.53B+2023.3%
2020$-703.38M-47.4%
2019$-477.08M-15.8%
2018$-412.05M-75.1%
2017$-235.33M-12.8%
2016$-208.66M-